272 related articles for article (PubMed ID: 34941875)
21. Impact of long-term tenofovir disoproxil fumarate on incidence of hepatocellular carcinoma in patients with chronic hepatitis B.
Kim WR; Loomba R; Berg T; Aguilar Schall RE; Yee LJ; Dinh PV; Flaherty JF; Martins EB; Therneau TM; Jacobson I; Fung S; Gurel S; Buti M; Marcellin P
Cancer; 2015 Oct; 121(20):3631-8. PubMed ID: 26177866
[TBL] [Abstract][Full Text] [Related]
22. SARS-CoV-2 seropositivity and subsequent infection risk in healthy young adults: a prospective cohort study.
Letizia AG; Ge Y; Vangeti S; Goforth C; Weir DL; Kuzmina NA; Balinsky CA; Chen HW; Ewing D; Soares-Schanoski A; George MC; Graham WD; Jones F; Bharaj P; Lizewski RA; Lizewski SE; Marayag J; Marjanovic N; Miller CM; Mofsowitz S; Nair VD; Nunez E; Parent DM; Porter CK; Santa Ana E; Schilling M; Stadlbauer D; Sugiharto VA; Termini M; Sun P; Tracy RP; Krammer F; Bukreyev A; Ramos I; Sealfon SC
Lancet Respir Med; 2021 Jul; 9(7):712-720. PubMed ID: 33865504
[TBL] [Abstract][Full Text] [Related]
23. Impact of occult hepatitis B virus infection and prior hepatitis B virus infection on development of hepatocellular carcinoma in patients with liver cirrhosis due to hepatitis C virus.
Adachi S; Shibuya A; Miura Y; Takeuchi A; Nakazawa T; Saigenji K
Scand J Gastroenterol; 2008; 43(7):849-56. PubMed ID: 18584524
[TBL] [Abstract][Full Text] [Related]
24. Impact of the COVID-19 pandemic on patients with liver cirrhosis-the experience of a tertiary center in Germany.
Höner Zu Siederdissen C; Schultalbers M; Wübbolding M; Lechte GS; Laser H; Cornberg M; Wedemeyer H; Maasoumy B
Z Gastroenterol; 2021 Sep; 59(9):954-960. PubMed ID: 34507374
[TBL] [Abstract][Full Text] [Related]
25. Factors Associated With Increased Risk of De Novo or Recurrent Hepatocellular Carcinoma in Patients With Cirrhosis Treated With Direct-Acting Antivirals for HCV Infection.
Degasperi E; D'Ambrosio R; Iavarone M; Sangiovanni A; Aghemo A; Soffredini R; Borghi M; Lunghi G; Colombo M; Lampertico P
Clin Gastroenterol Hepatol; 2019 May; 17(6):1183-1191.e7. PubMed ID: 30613002
[TBL] [Abstract][Full Text] [Related]
26. Effect of virological response to entecavir on the development of hepatocellular carcinoma in hepatitis B viral cirrhotic patients: comparison between compensated and decompensated cirrhosis.
Kim SS; Hwang JC; Lim SG; Ahn SJ; Cheong JY; Cho SW
Am J Gastroenterol; 2014 Aug; 109(8):1223-33. PubMed ID: 24890440
[TBL] [Abstract][Full Text] [Related]
27. Response to chemotherapy improves hepatic reserve for patients with hepatocellular carcinoma and Child-Pugh B cirrhosis.
Terashima T; Yamashita T; Arai K; Kawaguchi K; Kitamura K; Yamashita T; Sakai Y; Mizukoshi E; Honda M; Kaneko S
Cancer Sci; 2016 Sep; 107(9):1263-9. PubMed ID: 27315783
[TBL] [Abstract][Full Text] [Related]
28. High prevalence of SARS-CoV-2 infection among symptomatic healthcare workers in a large university tertiary hospital in São Paulo, Brazil.
Buonafine CP; Paiatto BNM; Leal FB; de Matos SF; de Morais CO; Guerra GG; Martuchelli MVV; Oliveira DBL; Durigon EL; Soares CP; Candido ED; Telezynski BL; Sáfadi MAP; Almeida FJ
BMC Infect Dis; 2020 Dec; 20(1):917. PubMed ID: 33267836
[TBL] [Abstract][Full Text] [Related]
29. Increased risk of hepatocellular carcinoma in chronic hepatitis B patients with transient elastography-defined subclinical cirrhosis.
Kim MN; Kim SU; Kim BK; Park JY; Kim DY; Ahn SH; Song KJ; Park YN; Han KH
Hepatology; 2015 Jun; 61(6):1851-9. PubMed ID: 25643638
[TBL] [Abstract][Full Text] [Related]
30. Genotype C hepatitis B virus infection is associated with an increased risk of hepatocellular carcinoma.
Chan HL; Hui AY; Wong ML; Tse AM; Hung LC; Wong VW; Sung JJ
Gut; 2004 Oct; 53(10):1494-8. PubMed ID: 15361502
[TBL] [Abstract][Full Text] [Related]
31. Measures of infection prevention and incidence of SARS-CoV-2 infections in cancer patients undergoing radiotherapy in Germany, Austria and Switzerland.
Matuschek C; Fischer JC; Combs SE; Fietkau R; Corradini S; Zänker K; Bölke E; Djiepmo-Njanang FJ; Tamaskovics B; Fischer JE; Stuschke M; Pöttgen C; Förster R; Zwahlen DR; Papachristofilou A; Ganswindt U; Pelka R; Schneider EM; Feldt T; Jensen BEO; Häussinger D; Knoefel WT; Kindgen-Milles D; Pedoto A; Grebe O; van Griensven M; Budach W; Haussmann J
Strahlenther Onkol; 2020 Dec; 196(12):1068-1079. PubMed ID: 32914236
[TBL] [Abstract][Full Text] [Related]
32. Clinical characteristics and outcome of a cohort of 101 patients with hepatocellular carcinoma.
Rabe C; Pilz T; Klostermann C; Berna M; Schild HH; Sauerbruch T; Caselmann WH
World J Gastroenterol; 2001 Apr; 7(2):208-15. PubMed ID: 11819762
[TBL] [Abstract][Full Text] [Related]
33. SARS-CoV-2 nosocomial infection acquired in a French university hospital during the 1st wave of the Covid-19 pandemic, a prospective study.
Landoas A; Cazzorla F; Gallouche M; Larrat S; Nemoz B; Giner C; Le Maréchal M; Pavese P; Epaulard O; Morand P; Mallaret MR; Landelle C
Antimicrob Resist Infect Control; 2021 Aug; 10(1):114. PubMed ID: 34353356
[TBL] [Abstract][Full Text] [Related]
34. Surveillance programme of cirrhotic patients for early diagnosis and treatment of hepatocellular carcinoma: a cost effectiveness analysis.
Bolondi L; Sofia S; Siringo S; Gaiani S; Casali A; Zironi G; Piscaglia F; Gramantieri L; Zanetti M; Sherman M
Gut; 2001 Feb; 48(2):251-9. PubMed ID: 11156649
[TBL] [Abstract][Full Text] [Related]
35. From first to second wave: follow-up of the prospective COVID-19 cohort (KoCo19) in Munich (Germany).
Radon K; Bakuli A; Pütz P; Le Gleut R; Guggenbuehl Noller JM; Olbrich L; Saathoff E; Garí M; Schälte Y; Frahnow T; Wölfel R; Pritsch M; Rothe C; Pletschette M; Rubio-Acero R; Beyerl J; Metaxa D; Forster F; Thiel V; Castelletti N; Rieß F; Diefenbach MN; Fröschl G; Bruger J; Winter S; Frese J; Puchinger K; Brand I; Kroidl I; Wieser A; Hoelscher M; Hasenauer J; Fuchs C;
BMC Infect Dis; 2021 Sep; 21(1):925. PubMed ID: 34493217
[TBL] [Abstract][Full Text] [Related]
36. Efficacy and cost of a hepatocellular carcinoma screening program at an Australian teaching hospital.
Qian MY; Yuwei J R; Angus P; Schelleman T; Johnson L; Gow P
J Gastroenterol Hepatol; 2010 May; 25(5):951-6. PubMed ID: 20546449
[TBL] [Abstract][Full Text] [Related]
37. Comparison of different prognostic scores for patients with cirrhosis hospitalized with SARS-CoV-2 infection.
Mendizabal M; Ridruejo E; Piñero F; Anders M; Padilla M; Toro LG; Torre A; Montes P; Urzúa A; Gonzalez Ballerga E; Silveyra MD; Michelato D; Díaz J; Peralta M; Pages J; García SR; Gutierrez Lozano I; Macias Y; Cocozzella D; Chavez-Tapia N; Tagle M; Dominguez A; Varón A; Vera Pozo E; Higuera-de la Tijera F; Bustios C; Conte D; Escajadillo N; Gómez AJ; Tenorio L; Castillo Barradas M; Schinoni MI; Bessone F; Contreras F; Nazal L; Sanchez A; García M; Brutti J; Cabrera MC; Miranda-Zazueta G; Rojas G; Cattaneo M; Castro-Narro G; Rubinstein F; Silva MO
Ann Hepatol; 2021; 25():100350. PubMed ID: 33864948
[TBL] [Abstract][Full Text] [Related]
38. A Reminder of Skin Cancer During the COVID-19 Pandemic.
Šitum M; Filipović N; Buljan M
Acta Dermatovenerol Croat; 2021 Apr; 291(1):58. PubMed ID: 34477068
[TBL] [Abstract][Full Text] [Related]
39. Antibody to hepatitis B core antigen and risk for hepatitis C-related hepatocellular carcinoma: a prospective study.
Ikeda K; Marusawa H; Osaki Y; Nakamura T; Kitajima N; Yamashita Y; Kudo M; Sato T; Chiba T
Ann Intern Med; 2007 May; 146(9):649-56. PubMed ID: 17470833
[TBL] [Abstract][Full Text] [Related]
40. Squamous cell carcinoma antigen-IgM is associated with hepatocellular carcinoma in patients with cirrhosis: A prospective study.
Biasiolo A; Trotta E; Fasolato S; Ruvoletto M; Martini A; Gallotta A; Fassina G; Angeli P; Gatta A; Pontisso P
Dig Liver Dis; 2016 Feb; 48(2):197-202. PubMed ID: 26614642
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
